Fungalinfections have taken a new spectrum due to the increased incidence ofmulti-drug resistant fungal pathogens. Freedom of choice for drugs to treatfungal infections is also narrow because of lesser probability of discovering drugsthat would bypass affecting human cells and target fungal cells producing fewerside effects in patients.